Table 2.

Outcomes of VA-ECMO support stratified by the initial cause of cardiogenic shock.

Indication for VA-ECMO support	Reported survival (%)
Acute myocardial infarction	33.8–66.7
Cardiomyopathy	35.7–57.0
COVID-19 infection	0–36.6
eCPR	8.8–54.0
Fulminant myocarditis	60.0–74.0
Primary graft failure post heart transplantation	50.0–84.2
Massive pulmonary embolism	38.5–53.1
Cardiomyopathy in the setting of sepsis	59.8–75.0

eCPR, extracorporeal cardiopulmonary resuscitation.